April 28, 2020
Bristol-Myers Squibb announced that the sale and distribution of all strengths of Coumadin (Warfarin Sodium) tablets will be discontinued in the United States, Canada, Latin America, and Saudi Arabia, due to an unexpected manufacturing issue. It will begin on June… Continue Reading…
Recent Comments